Your browser doesn't support javascript.
loading
Inferior cure rate in pilot study of 4-week glecaprevir/pibrentasvir treatment with or without ribavirin of chronic hepatitis C.
Madsen, Lone W; Christensen, Peer B; Fahnøe, Ulrik; Pedersen, Martin S; Bukh, Jens; Øvrehus, Anne.
Afiliação
  • Madsen LW; Department of Infectious Diseases, Odense University Hospital, Odense, Denmark.
  • Christensen PB; OPEN, Odense Patient data Explorative Network, Odense University Hospital, Odense, Denmark.
  • Fahnøe U; Clinical Institute, University of Southern Denmark, Odense, Denmark.
  • Pedersen MS; Department of Infectious Diseases, Odense University Hospital, Odense, Denmark.
  • Bukh J; OPEN, Odense Patient data Explorative Network, Odense University Hospital, Odense, Denmark.
  • Øvrehus A; Clinical Institute, University of Southern Denmark, Odense, Denmark.
Liver Int ; 41(11): 2601-2610, 2021 11.
Article em En | MEDLINE | ID: mdl-34154034
Assuntos
Palavras-chave
Texto completo
Imprimir
XML
PubMed Links
Buscar no Google

Texto completo: 1 Base de dados: MEDLINE Assunto principal: Ribavirina / Hepatite C Crônica Idioma: En Ano de publicação: 2021 Tipo de documento: Article
Texto completo
Imprimir
XML
PubMed Links
Buscar no Google

Texto completo: 1 Base de dados: MEDLINE Assunto principal: Ribavirina / Hepatite C Crônica Idioma: En Ano de publicação: 2021 Tipo de documento: Article